Evidence map›Paper›PMID 26137438›Full record

ArticleMolecular metabolism2015

A major role of insulin in promoting obesity-associated adipose tissue inflammation.

David J Pedersen, Adilson Guilherme, Laura V Danai, Lauren Heyda, Anouch Matevossian, Jessica Cohen, Sarah M Nicoloro, Juerg Straubhaar, Hye Lim Noh, DaeYoung Jung and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Enhanced fatty acid oxidation in osteoprogenitor cells provides protection from high-fat diet induced bone dysfunction.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. The Metabolic Syndrome, a Human Disease.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

David J PedersenProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Adilson GuilhermeProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Laura V DanaiProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Lauren HeydaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Anouch MatevossianProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Jessica CohenProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Sarah M NicoloroProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Juerg StraubhaarProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Hye Lim NohProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA ; Division of Endocrinology, Metabolism, and Diabetes, University of Massachusetts Medical School, Worcester, MA 01605, USA.
DaeYoung JungProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA ; Division of Endocrinology, Metabolism, and Diabetes, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Jason K KimProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA ; Division of Endocrinology, Metabolism, and Diabetes, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Michael P CzechProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
University of Massachusetts Chan Medical School · US

Funding

Insulin Signaling and Metabolic Regulation in AdipocytesR37DK030898 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1996 to 2021
$7.2M
Insulin Signaling and Metabolic Regulation in AdipocytesR01DK030898 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2011
$2.7M
UMass Mouse Metabolic Phenotyping CenterU24DK093000 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIM, JASON K · 2011 to 2015
$2.1M
Chemically-conjugated glucan particles for delivery of therapeutic siRNAF32DK098879 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI COHEN, JESSICA LYNN · 2013 to 2015
$159k
NIDDK NIH HHS F32 DK098879NIDDK NIH HHS R01 DK030898NIDDK NIH HHS R37 DK030898NIDDK NIH HHS U24 DK093000
6 · The paper itself

Abstract

objectiveAdipose tissue (AT) inflammation is associated with systemic insulin resistance and hyperinsulinemia in obese rodents and humans. A longstanding concept is that hyperinsulinemia may promote systemic insulin resistance through downregulation of its receptor on target tissues. Here we tested the novel hypothesis that insulin also impairs systemic insulin sensitivity by specifically enhancing adipose inflammation.

methodsCirculating insulin levels were reduced by about 50% in diet-induced and genetically obese mice by treatments with diazoxide or streptozotocin, respectively. We then examined AT crown-like structures, macrophage markers and pro-inflammatory cytokine expression in AT. AT lipogenesis and systemic insulin sensitivity was also monitored. Conversely, insulin was infused into lean mice to determine its affects on the above parameters.

resultsLowering circulating insulin levels in obese mice by streptozotocin treatment decreased macrophage content in AT, enhancing insulin stimulated Akt phosphorylation and de novo lipogenesis (DNL). Moreover, responsiveness of blood glucose levels to injected insulin was improved by streptozotocin and diazoxide treatments of obese mice without changes in body weight. Remarkably, even in lean mice, infusion of insulin under constant euglycemic conditions stimulated expression of cytokines in AT. Consistent with these findings, insulin treatment of 3T3-L1 adipocytes caused a 10-fold increase in CCL2 mRNA levels within 6 h, which was blocked by the ERK inhibitor PD98059.

conclusionTaken together, these results indicate that obesity-associated hyperinsulinemia unexpectedly drives AT inflammation in obese mice, which in turn contributes to factors that suppress insulin-stimulated adipocyte DNL and systemic insulin sensitivity.

Indexed as

Adipose tissueHyperinsulinemiaInflammationInsulin resistanceObesity

Identifiers

PMID26137438
PMCPMC4481426
OpenAlexW2172026176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.